Ray Dalio
BHVN icon

Ray Dalio’s Biohaven BHVN Stock Holding History

Ray Dalio’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,060
Closed -$301K – 1062
2025
Q3 		$301K Buy
+20,060
New +$292K ﹤0.01% 964

Other funds holding BHVN

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ray Dalio's BHVN Position: Q4 2025 in Review

Ray Dalio sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 20,060 shares — an estimated $301K sold.

Ray Dalio first reported a position in BHVN in Q3 2025 and held it in 1 quarter. The position peaked at $301K in Q3 2025. 272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Ray Dalio reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • Ray Dalio sold 20,060 Biohaven shares in Q4 2025, an estimated $301K.
  • Ray Dalio first reported a position in Biohaven in Q3 2025 and held it in 1 quarter.
  • Ray Dalio's Biohaven position peaked at $301K in Q3 2025.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Bridgewater Associates's 13F filing for Q4 2025, filed 13 Feb 2026.